Skip to main content
. Author manuscript; available in PMC: 2010 Jul 14.
Published in final edited form as: Transplant Proc. 1990 Feb;22(1):25–34.

Table 5.

Treatment Groups, Survival, Duration of Therapy, and Cause of Death in Patients Who Died While on FK 506 Therapy

Patient Treatment Group Survival (d) Duration of FK 506 Therapy (d) Cause of Death
D.M. Liver primary 14 14 Cardiac arrest
M.S.* Liver primary 10 10 Cerebellar hemorrhage
A.N. Liver rescue 152 5 Necrotizing pneumonia
G.S. Liver rescue 28 13 Sepsis, ARDS, pancreatitis
L.S. Liver rescue 17 6 Sepsis, ARDS, DIC
D.M. Liver rescue 30 20 Sepsis

Abbreviations: ARDS, adult respiratory distress syndrome; DIC, disseminated intravascular coagulation.

*

Patient not included in primary list reported in Table 4.

Patient removed from FK 506 after fiver failure from fulminant hepatitis B.